Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In-office Repair of Chronic Tympanic Membrane Perforations Using FGF2
NCT06448039Phase 2Active, not recruiting
- Start
- Jun 2024
- Primary completion
- May 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of trafermin in chronic tympanic membrane perforation. Started Jun 2024; status: active, not recruiting.
02
Drugs
trafermin
03
Conditions
chronic tympanic membrane perforation
Beyond the preview
Go deeper on NCT06448039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06448039.